Results for “”

Entry Author Date Location
Lundbeck Paying Nearly $2B for Alder to Follow Migraine Rivals to Market 09/16/19 National
Why Menlo Ventures Backed Its First Construction Tech Firm 09/16/19 San Francisco
BACEless: Eisai, Biogen Pull Plug on Alzheimer’s Drug in Final Stage 09/13/19 New York
Boston Tech Watch: Neural Galaxy, Link Ventures, & More Epstein Fallout 09/13/19 Boston
Booming CS Demand Brings Ex-Acquia CEO Back to His UW Roots 09/13/19 Wisconsin
The Winners of the 2019 Xconomy Awards Boston Are… 09/12/19 Boston
John Halamka, Livongo Health & AI Progress at X·CON on Oct. 22 09/12/19 Boston
FDA Doesn’t Shell Peanut Allergy Drug Pre-Hearing, Aimmune Shares Climb 09/11/19 San Francisco
Phil Sharp, CRISPR’ing the Heart & the Duchenne Data Gap on Oct. 17 09/11/19 Boston
After First Look at House Drug Plan, Stocks Rise Slightly 09/10/19 National
Herceptin Inventors, Immunology Pioneers Take Home 2019 Lasker Awards 09/10/19 National
Shopify Buys 6 River Systems for $450M to Boost Fulfillment Centers 09/10/19 Boston
Challenging CRISPR, Trucode Raises $34M for New Gene-Editing System 09/10/19 San Francisco
Epstein Fallout: Joi Ito Resigns From MIT Media Lab, Multiple Boards 09/09/19 Boston
As New CEO of Cerevel, Coles Moves From One Neuro Startup to Another 09/09/19 Boston
At Big Lung Cancer Meeting, Lights Shine on KRAS, Drug Combos & More 09/09/19 National
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone 09/06/19 National
Boston Tech Watch: MIT Epstein, Notarize Cash, New Carbonite Execs 09/06/19 Boston
Novartis & IFM Team Up Again, With Buyout Option for Autoimmune R&D 09/05/19 Boston
Cogito Raises $20M to Expand Call Center Emotional Intelligence 09/05/19 Boston
Vertex Bets $950M on Semma and a Stem Cell Therapy for Diabetes 09/03/19 Boston
With FDA’s Eye on JAK Drugs, Concert Moves One Ahead For Hair Loss 09/03/19 Boston
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing 09/02/19 New York
Patent Challenge to Alexion Proceeds, But No Amgen Biosimilar Yet 08/30/19 Boston
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More 08/30/19 National
Boston Tech Watch: DraftKings Drives, The Engine Revs, NuTonomy Swaps 08/30/19 Boston
NuTonomy Switches to Chrysler For More Elbow Room in Self-Driving Cars 08/27/19 Boston
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.) 08/26/19 National
VMware: “We Bought Carbon Black for $2.1B!” Analysts: “Oh… Why?” 08/23/19 Boston
GSK’s Cancer Comeback Continues With Data for Multiple Myeloma Drug 08/23/19 National
Page 1 of 132 next page »